Stock HBRM HERBORIUM GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Herborium Group, Inc. Share Price

Equities

HBRM

US42703A2087

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 09:12:40 17/05/2024 pm IST 		5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Herborium Group, Inc. 0.00% +9,900.00%
2021 Herborium Group, Inc. Moves into Manufacturing Phase for Its New Protein Bars CI
2021 Herborium Group Progresses with Distribution Agreements for Acnease and Cosmeceuticals to Take Advantage of $8 Billion French Cosmetic Market CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2010 262K 21.81M Sales 2011 234K 19.52M Capitalization 210K 17.52M
Net income 2010 - 0 Net income 2011 - 0 EV / Sales 2010 10.7 x
Net Debt 2010 588K 48.92M Net Debt 2011 621K 51.72M EV / Sales 2011 3.55 x
P/E ratio 2010
-4.35 x
P/E ratio 2011
-0.97 x
Employees 5
Yield 2010 *
-
Yield 2011
-
Free-Float 100%
More Fundamentals * Assessed data

Chart Herborium Group, Inc.

Dynamic Chart

Latest news about Herborium Group, Inc.

Herborium Group, Inc. Moves into Manufacturing Phase for Its New Protein Bars CI
Herborium Group Progresses with Distribution Agreements for Acnease and Cosmeceuticals to Take Advantage of $8 Billion French Cosmetic Market CI
Herborium to Develop Proprietary Protein Bar with Unique Skin Benefits and Weight Management Properties CI
Herborium Group, Inc. Announces Joining of Ashok N. Vasvani to Herborium Team CI
Herborium Group, Inc. Moves to the Next Level in Building Disruptive, Integrated, Natural Medicine Content and Commerce Platform CI
Herborium Group, Inc. Announces Unique Herbal Acne Treatment AcnEase to Enter the Fastest Growing Asia Pacific Market CI
Herborium Group, Inc. Introduces Proprietary Two- In- One Biodegradable, Multi-Use Facial Mask CI
Herborium Group, Inc. Reports Sales Results for the Second Quarter and Six Months of 2015 CI
Herborium Group, Inc. Announces Earnings Results for the First Quarter of 2015 CI
Herborium Group, Inc. Announces Sales Results for the First Quarter of Fiscal 2015 CI
Herborium Group, Inc. Announces Earnings Results for the Full Year 2014 CI
Herborium(R) Group, Inc. Announces Earnings Results for the Third Quarter of 2014 and Sales Results for the First Three Quarters of 2014 CI
Herborium Group, Inc. Reports Sales Results for the Second Quarter and Six Months Ended May 31, 2014 CI
Herborium Group, Inc. Reports Sales Results for the First Quarter of 2014 CI
Herborium Group, Inc. Announces Sales Results for the Year 2013 CI
More news

Press releases Herborium Group, Inc.

HBRM CEO Discusses Future Opportunities in Tech-Driven Natural Wellness and Beauty Sectors (Corrected Version) AQ
Herborium Group, Inc. (OTC:HBRM) CEO Discusses Future Opportunities in Tech-Driven Natural Wellness and Beauty Sectors AQ
CapitalGainsReport: Sub-Penny Spotlight (HBRM, PLPL, CNNA, AITX) AQ
Sub-Penny Spotlight (HBRM, PLPL, CNNA, AITX) AQ
CapitalGainsReport: Thriving Natural Beauty & Wellness Stocks (HBRM, SKIN, NUS, NTCO) AQ
More press releases

Highs and lows

1 week
0.00
Extreme 0
0.00
1 month
0.00
Extreme 0
0.00
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.01
10 years
0.00
Extreme 0
0.10
More quotes

Managers and Directors - Herborium Group, Inc.

Managers TitleAgeSince
Agnes Olszewski CEO
 Chief Executive Officer 67 04/02/04
John Donahue AUD
 Comptroller/Controller/Auditor 74 -
Members of the board TitleAgeSince
Agnes Olszewski CEO
 Chief Executive Officer 67 04/02/04
More insiders

Quotes

Date Price Change Volume
17/24/17 0.0001 0.00% 1,052,981
16/24/16 0.0001 0.00% 3,141,060
15/24/15 0.0001 0.00% 600,000
14/24/14 0.0001 0.00% 2,490,000
10/24/10 0.0001 0.00% 1,702,831

Delayed Quote OTC Markets, May 17, 2024 at 09:12 pm IST

More quotes

Company Profile

Herborium Group, Inc. is a developer, licensor and marketer of herbal ingredient-based medicines and wellness products. The Company's flagship product, AcnEase is an herbal, oral treatment for patients with acne or rosacea. The Company serves clients worldwide. It is engaged in the development of a series of the artificial intelligence (AI)-based content products related to dermatological and beauty space. In addition to AcnEase, the Company has secured a pipeline of product candidates. The products include protein skin bar and adjunct cutting age skincare products based on stem cell technology. it is also ready for commercialization of new products line of natural sexual health and performance enhancing products for men and women. The Company owns all formulations for its proprietary products.
Sector
Biotechnology & Medical Research
More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
HERBORIUM GROUP, INC. Stock Herborium Group, Inc.
+9,900.00% 1.09M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.42% 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.84% 104B
BIONTECH SE Stock BioNTech SE
-14.15% 22.41B
ARGENX SE Stock argenx SE
-1.05% 22.28B
GENMAB A/S Stock Genmab A/S
-5.29% 19.07B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.29% 18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-4.16% 17.89B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.99% 14.28B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.24% 12.55B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. HBRM Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW